Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||0.40%||160.11||0.7%||$1208.66m|
|MRK||Merck & Co., Inc.||0.00%||76.43||0.7%||$966.72m|
|BMY||Bristol-Myers Squibb Co.||0.41%||63.84||1.0%||$725.84m|
|LLY||Eli Lilly & Co.||0.33%||183.13||1.1%||$599.57m|
|RPRX||Royalty Pharma Plc||1.67%||42.12||0.2%||$163.20m|
|ATNF||180 Life Sciences Corp.||-3.06%||10.46||0.0%||$62.67m|
|BHVN||Biohaven Pharmaceutical Holding Co. Ltd.||2.94%||74.92||0.0%||$61.28m|
Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals. The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity. The Biopharmaceuticals segment offers products for haemophilia; growth hormone therapy; and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in BagsvÃ¦rd, Denmark.